Methotrexate-Inadequate Response Study

NCT00559585 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2492

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis (RA)

Interventions

DRUG: Subcutaneous (SC) Abatacept
DRUG: Intravenous (IV) Abatacept

Sponsor

Bristol-Myers Squibb